Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Procedure, Device
  • Participants: 39
  • Start Date: April 2021
A Phase 2 Study of Fluorescence Detection of Adult Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
Clinical Trial
  • Status: Recruiting
  • Participants: 10000
  • Start Date: June 10, 2020
Rare Obesity Cohorts With Food Behavioral Disorders : Better Diagnosis for Better Treatment
Search for trials
Clinical Trial
  • Status: Recruiting
  • Participants: 400
  • Start Date: July 16, 2019
A Prospective Longitudinal Quality of Life Study in Patients Undergoing Endoscopic Endonasal Skull Base Surgery
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 27
  • Start Date: June 27, 2019
A Phase 0/Feasibility Trial of Tocilizumab in Children and Adolescents With Newly- Diagnosed or Recurrent/Progressive Adamantinomatous Craniopharyngioma
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Procedure
  • Participants: 250
  • Start Date: March 12, 2019
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 1500
  • Start Date: January 1, 2018
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 50
  • Start Date: November 7, 2017
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors: A Pilot Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 36
  • Start Date: August 4, 2017
Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: October 2016
Intranasal Oxytocin to Promote Weight Loss in Children, Adolescents, and Adults With Brain Tumors and Hypothalamic Obesity Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation, Procedure
  • Participants: 140
  • Start Date: June 22, 2016
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
Showing 1-12 of 21